Treatment of Relapsed or Refractory B-cell Lymphoma With Chimeric Antigen Receptor (CAR) T-cell Therapy Produced by a New Technology
Clinical trial NCT06378190 · RECRUITING
Trial details
- NCT number
- NCT06378190
- Sponsor
- Instituto de Investigación Biomédica de Salamanca
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-11
- Primary completion
- 2029-07-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.